{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:03Z","timestamp":1760057223917,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ajem.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T02:09:21Z","timestamp":1525658961000},"page":"1526.e1-1526.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute stent thrombosis: Should preventative measures start in the emergency department?"],"prefix":"10.1016","volume":"36","author":[{"given":"Getaw Worku","family":"Hassen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheila","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basel","family":"Alhadad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaleh","family":"Azhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Ann","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Zavaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2018.05.006_bb0005","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.jacc.2014.02.607","article-title":"Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study","volume":"63","author":"Nakano","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ajem.2018.05.006_bb0010","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/eurheartj\/ehp436","article-title":"Stent thrombosis: who's guilty?","volume":"30","author":"Montalescot","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ajem.2018.05.006_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcin.2014.11.002","article-title":"Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography)","volume":"8","author":"Clemmensen","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ajem.2018.05.006_bb0020","first-page":"e78","article-title":"ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"American College of Emergency, P","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ajem.2018.05.006_bb0025","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2018.05.006_bb0030","doi-asserted-by":"crossref","first-page":"T23","DOI":"10.4244\/EIJV10STA5","article-title":"Management of ST-elevation myocardial infarction according to European and American guidelines","volume":"10","author":"Windecker","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ajem.2018.05.006_bb0035","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry","volume":"53","author":"van Werkum","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ajem.2018.05.006_bb0040","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2007.01.094","article-title":"Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis","volume":"49","author":"Buonamici","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ajem.2018.05.006_bb0045","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1538-7836.2007.02775.x","article-title":"Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel","volume":"5","author":"Brandt","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ajem.2018.05.006_bb0050","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1001\/jama.2011.1880","article-title":"CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis","volume":"306","author":"Holmes","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2018.05.006_bb0055","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehp157","article-title":"Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease","volume":"30","author":"Varenhorst","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ajem.2018.05.006_bb0060","first-page":"40","article-title":"HEAT-PPCI: a clear and welcome win for heparin","volume":"2014","author":"ElGuindy","year":"2014","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.ajem.2018.05.006_bb0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.thromres.2006.08.012","article-title":"Clopidogrel resistance?","volume":"120","author":"Gurbel","year":"2007","journal-title":"Thromb. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2018.05.006_bb0070","first-page":"S19","article-title":"Stent thrombosis: role of compliance and nonresponsiveness to antiplatelet therapy","volume":"8","author":"Gurbel","year":"2007","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.ajem.2018.05.006_bb0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH08-05-0313","article-title":"Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease","volume":"100","author":"Braun","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ajem.2018.05.006_bb0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals","volume":"45","author":"Serebruany","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"66","key":"10.1016\/j.ajem.2018.05.006_bb0085","first-page":"e69-16","article-title":"A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation","volume":"153","author":"Brandt","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ajem.2018.05.006_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.thromres.2006.01.019","article-title":"Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study","volume":"119","author":"Malinin","year":"2007","journal-title":"Thromb. Res."},{"issue":"562","key":"10.1016\/j.ajem.2018.05.006_bb0095","first-page":"e561","article-title":"Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin","volume":"157","author":"Varenhorst","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ajem.2018.05.006_bb0100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2018.05.006_bb0105","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/CIRCULATIONAHA.108.857722","article-title":"Can we override clopidogrel resistance?","volume":"119","author":"Pena","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2018.05.006_bb0110","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2018.05.006_bb0115","doi-asserted-by":"crossref","first-page":"g6419","DOI":"10.1136\/bmj.g6419","article-title":"Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors","volume":"349","author":"Bangalore","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajem.2018.05.006_bb0120","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jcin.2016.09.020","article-title":"Use and effectiveness of bivalirudin versus unfractionated heparin for percutaneous coronary intervention among patients with ST-segment elevation myocardial infarction in the United States","volume":"9","author":"Secemsky","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ajem.2018.05.006_bb0125","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","article-title":"Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study","volume":"52","author":"Wenaweser","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ajem.2018.05.006_bb0130","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1253\/circj.CJ-11-0581","article-title":"Mechanisms of non-fatal stent-related myocardial infarction late following coronary stenting with drug-eluting stents and bare metal stents. Insights from optical coherence tomography","volume":"75","author":"Davlouros","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ajem.2018.05.006_bb0135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijcard.2015.02.087","article-title":"A multidisciplinary approach in early stent thrombosis: Insights from optical coherence tomography and platelet reactivity testing","volume":"184","author":"Hernandez-Perez","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ajem.2018.05.006_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCINTERVENTIONS.113.000797","article-title":"Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation","volume":"7","author":"Im","year":"2014","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ajem.2018.05.006_bb0145","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.ijcard.2014.04.095","article-title":"Use of optical coherence tomography in acute clinical settings","volume":"174","author":"Vollenbroich","year":"2014","journal-title":"Int. J. Cardiol."}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675718303693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675718303693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:41:32Z","timestamp":1760024492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675718303693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0735675718303693"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2018.05.006","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute stent thrombosis: Should preventative measures start in the emergency department?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}